
Sign up to save your podcasts
Or
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
3.8
4747 ratings
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
130 Listeners
319 Listeners
160 Listeners
862 Listeners
494 Listeners
22 Listeners
32 Listeners
87 Listeners
135 Listeners
1,082 Listeners
39 Listeners
186 Listeners
415 Listeners
35 Listeners
135 Listeners